Immunogenicity and Safety of a Fully Liquid DTaP-IPV-Hep B-PRP-T Vaccine at 2-4-6 Months of Age in Peru

Journal of Vaccines & Vaccination
doi 10.4172/2157-7560.1000128
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

Feasibility Study of the Immunogenicity and Safety of a Novel DTPw/Hib (PRP-T) Brazilian Combination Compared to a Licensed Vaccine in Healthy Children at 2, 4, and 6 Months of Age

Revista da Sociedade Brasileira de Medicina Tropical
ParasitologyInfectious DiseasesMicrobiology
2003English

Safety and Immunogenicity of Salmonella Typhi Ty21a Liquid Formulation Vaccine in 4 to 6 Year Old Thai Children

1993English

Protophone Development at 4-6 Months and 7-9 Months of Age

Communication Sciences and Disorders
LinguisticsHearingSpeechLanguageCommunication
2019English

Immunogenicity of a Combined DTPa-HB Vaccine Co-Administered With Haemophilus Influenzae Type B Conjugate Vaccine (PRP-T) for Primary and Booster Vaccinations

Brazilian Journal of Infectious Diseases
Infectious DiseasesMicrobiology
2005English

Safety and Immunogenicity of Haemophilus Influenzae Type B Conjugate Vaccine in Copd

Journal of Evolution of Medical and Dental Sciences
2016English

Figure 2: Average Faces of UCLP Subjects at Age (A) 3, (B) 6, (C) 9, and (D) 12 Months of Age.

English

Safety and Immunogenicity of Hepatitis B Vaccine: A Study on Iranian Navy Personnel

Vaccine Research
2014English

The Safety of Haemophilus Influenzae Type B/Polyribosylribitol Phosphate-Tetanus (Hib/PRP-T) Vaccine, Phase I Study

International Journal of Integrated Health Sciences
2015English

Safety and Immunogenicity of a Live Attenuated Mumps Vaccine

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy